JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN

Their core work

Goethe University Frankfurt is a major German research university with deep strengths in life sciences, neuroscience, and biomedical research. Their H2020 portfolio reveals a university that bridges fundamental biology — vascular biology, non-coding RNA, structural biology — with translational health applications such as drug discovery, neurodegeneration therapies, and precision diagnostics. They are a significant contributor to Europe's brain research infrastructure through the Human Brain Project and operate key structural biology facilities (NMR, electron microscopy, X-ray crystallography). Beyond biomedicine, they maintain pockets of expertise in high-energy physics, climate science, and digital communications.

What they specialise in

How they've shifted over time

In the early H2020 period (2015–2018), Goethe University's portfolio was broad and exploratory — spanning wireless communications hardware (W-band, MMIC chipsets), geochemistry (trace elements, isotopes in carbonates), structural biology infrastructure, and social sciences. From 2019 onward, the university sharply consolidated around biomedical and neuroscience themes: biomarkers, drug discovery, neurodegeneration, brain simulation, and health data analytics dominate their recent keywords. This shift reflects a strategic pivot from a scattered multi-disciplinary presence to a focused life sciences and translational medicine powerhouse.

Goethe University is consolidating around neuroscience, biomarker-driven drug discovery, and computational brain research — expect their future proposals to center on precision medicine and neuro-health.

How they like to work

With 38 of 110 projects as coordinator (35%), Goethe University takes the lead frequently — especially in ERC Advanced Grants and focused biomedical projects — while also functioning as a reliable consortium partner in large-scale research infrastructures. Their network of 1,037 unique partners across 49 countries signals a hub organization that builds new partnerships project by project rather than recycling the same consortia. This makes them accessible to new partners and comfortable working in both intimate research teams and large multi-national consortia.

With 1,037 unique consortium partners across 49 countries, Goethe University operates one of the most extensive collaboration networks among German universities in H2020. Their reach spans all of Europe with meaningful connections well beyond the EU, reflecting their involvement in flagship projects like the Human Brain Project.

What sets them apart

Goethe University Frankfurt combines world-class vascular biology and non-coding RNA research (multiple ERC grants) with deep integration into Europe's brain research ecosystem through the Human Brain Project. Few universities offer this specific combination of cardiovascular molecular biology, neuroscience computation, and structural biology infrastructure under one roof. For consortium builders, they bring both the fundamental science credibility of a top German university and a proven track record of managing EU-funded coordination across diverse international teams.

Highlights from their portfolio

• Angiolnc
  EUR 2.5M ERC Advanced Grant coordinated by GUF on endothelial long non-coding RNAs — represents their peak funding for a single investigator-driven project in vascular biology.
• HBP SGA1
  Participation in the Human Brain Project, one of the EU's two flagship initiatives, connecting GUF to Europe's largest neuroscience infrastructure spanning neuroinformatics, simulation, and neuromorphic computing.
• NOVA
  EUR 1.5M coordinated project on non-coding RNA in vascular ageing, running 6 years (2015–2021), demonstrating GUF's sustained leadership in RNA-based cardiovascular research.